Author

Mark Hudson 1

1 Freeman Hospital,London,United

Cirrhosis in over 16s: assessment and management

Iain Brew, Andrew Fowell, Lynda Greenslade, Phillip Harrison, Mark Hudson, Andrew Langford, Susan McRae, Marsha Morgan, G. Mortimore, Valerie Ross

DERIVATION AND VALIDATION OF A STATISTICAL MODEL TO FORECAST LONG TERM ALL-CAUSE MORTALITY IN PEOPLE WITH CIRRHOSIS

Craig J. Currie, Daniel Murphy, Bharat Amlani, Ellen Berni, James Whitehouse, James Orr, Peter Conway, Mark Hudson

DERIVATION AND VALIDATION OF A STATISTICAL MODEL TO FORECAST THREE-MONTH, ALL CAUSE MORTALITY IN SUBJECTS ADMITTED WITH INCIDENT DIAGNOSIS OF CIRRHOSIS

Craig J. Currie, Daniel Murphy, Bharat Amlani, Ellen Berni, James Whitehouse, Peter Conway, James Orr, Mark Hudson

Guidelines on the management of abnormal liver blood tests

Philip Newsome, Rob Cramb, S. Davison, John Dillon, Mark Foulerton, Edmund M Godfrey, Richard Hall, Ulrike Harrower, Mark Hudson, Andrew Langford, Anne Mackie, Robert Mitchell-Thain, Karen Sennett, Nicholas Sheron, Julia Verne, Martine Walmsley, Andrew Yeoman

HUNTING THE ENVIRONMENTAL TRIGGER IN PRIMARY SCLEROSING CHOLANGITIS: DISEASE CLUSTERING WITH AFFLUENCE AND RURAL LOCATION

Jessica Katharine Dyson, Alasdair Blain, David E.J. Jones, Steven P Rushton, Mark Hudson

LONG TERM PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY IS POSSIBLE WITH LACTULOSE ALONE BUT MORE EFFECTIVE IF COMBINED WITH RIFAXIMIN: A SYSTEMATIC REVIEW WITH NUMBER NEEDED TO TREAT ANALYSES OF RANDOMISED CONTROLLED TRIALS

Marcus Schuchmann, Nadya Mason, Mark Hudson

LONG TERM PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY IS POSSIBLE WITH LACTULOSE ALONE BUT MORE EFFECTIVE IF COMBINED WITH RIFAXIMIN: A SYSTEMATIC REVIEW WITH NUMBER NEEDED TO TREAT ANALYSES OF RANDOMISED CONTROLLED TRIALS

Mark Hudson

REAL WORLD IMPACT OF RIFAXIMIN-Α USE IN HEPATIC ENCEPHALOPATHY PATIENTS WITH ADVANCED LIVER DISEASE OR CONTINUED ALCOHOL MISUSE: A POST-HOC ANALYSIS OF THE IMPRESS STUDY

Mark Hudson, Paola Di Maggio, Riccardo Cipelli, Richard Aspinall

RIFAXIMIN-Α IS ASSOCIATED WITH REDUCTIONS IN EMERGENCY DEPARTMENT RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: REAL WORLD EVIDENCE FROM THE IMPRESS STUDY

Mark Hudson, Paola Di Maggio, Riccardo Cipelli, Richard Aspinall

THE IMPACT OF RIFAXIMIN-?LPHA ON NHS HOSPITAL RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: A RETROSPECTIVE OBSERVATIONAL STUDY (IMPRESS)

Richard Aspinall, Amr Radwan, Gabriel Shaya, Hanna Sodatonou, Paola Di Maggio, Riccardo Cipelli, Mark Hudson

Item 1 - 10 / 13
1
2